Elizabethtown, KYNCT05037825Now EnrollingIRB Ready

Non-Small-Cell Lung Carcinoma Clinical Trial in Elizabethtown, KY

Access cutting-edge non-small-cell lung carcinoma treatment through this clinical trial at a research site in Elizabethtown. Study-provided care at no cost to qualified participants.

Sponsored by VastBiome

Quick Self-Assessment

See if you qualify for this Elizabethtown location

Preparing your pre-screening questions…

Expert Care in Elizabethtown

Access non-small-cell lung carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small-cell lung carcinoma treatment provided free

Apply for This Elizabethtown Location

Check if you qualify for this non-small-cell lung carcinoma clinical trial in Elizabethtown, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Elizabethtown

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Elizabethtown site if eligible
  4. 4Begin participation

About This Non-Small-Cell Lung Carcinoma Study in Elizabethtown

The microbiome has the potential to serve as a robust biomarker of clinical response to immunotherapy. Additionally, microbial manipulation, through diet, exercise, prebiotics, probiotics, or microbially-derived metabolites, may prove to be beneficial in promoting anti-tumor immune responses. However, large prospective studies in humans with longitudinal sample collection and standardized methods are needed to understand how microbiota and their byproducts affect cancer therapies, particularly among patients undergoing identical therapy but experiencing different outcomes. The proposed observational study builds upon these hypotheses by proposing a large cohort design to further assess the associations between the gut microbiota (composition and function), host immune system, and ICI treatment efficacy across multiple cancer types.

Sponsor: VastBiome

Who Can Participate

Inclusion Criteria

Men or women ≥18 years of age
Screened negative for COVID-19 symptoms at time of consent, as per institutional policy and as applicable for the duration of the COVID-19 pandemic
Diagnosed with stages I-IV primary NSCLC, MM, TNBC or RCC
Plan to be treated at a partner cancer site with a checkpoint inhibitor (anti-PD-1, anti-PD-L1, or anti-CTLA-4) as a single agent or in combination with another checkpoint inhibitor or other treatment agent or modality (e.g., targeted therapy, chemotherapy, surgery, radiation, etc.) in accordance with FDA-labeled use of the agent
Able to provide informed consent and answer study questionnaires in either English or Spanish
Able to provide stool specimens for research purposes

Exclusion Criteria

Mental incapacity
Incarcerated individuals
Pregnancy (by self-report of pregnancy status)
Experiencing active brain metastasis/metastases
Treatment with checkpoint inhibitor in off-label capacity or through a clinical/interventional trial
Active participation in an immuno-oncology clinical/interventional trial or pharma-sponsored observational study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Elizabethtown?

Yes, this clinical trial (NCT05037825) has an active research site in Elizabethtown, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Small-Cell Lung Carcinoma Treatment Options in Elizabethtown, KY

If you're searching for non-small-cell lung carcinoma treatment options in Elizabethtown, KY, this clinical trial (NCT05037825) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Elizabethtown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small-cell lung carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small-cell lung carcinoma clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Elizabethtown, KY

See all lung cancer clinical trials recruiting in Elizabethtown — not just this study.

Browse Lung Cancer Trials in Elizabethtown

Ready to Join in Elizabethtown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Elizabethtown, KY